Tracy C. Kuo, Ph.D.
Affiliations: | Columbia University, New York, NY |
Area:
gene regulation in the immune systemGoogle:
"Tracy Kuo"Mean distance: 11.79
Parents
Sign in to add mentor| Kathryn L. Calame | grad student | 2005 | Columbia | |
| (Transcripton factors in late B-cell development.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Panowski SH, Kuo TC, Zhang Y, et al. (2019) Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma. Molecular Cancer Therapeutics |
| Sommer C, Boldajipour B, Kuo TC, et al. (2019) Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Kuo TC, Chen A, Harrabi O, et al. (2019) Abstract 562: Antibodies to Sirpα enhance innate and adaptive immune responses to promote anti-tumor activity Cancer Research. 79: 562-562 |
| Kauder SE, Kuo TC, Harrabi O, et al. (2018) ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile. Plos One. 13: e0201832 |
| Kauder SE, Kuo TC, Chen A, et al. (2017) ALX148 Is a High Affinity Sirpα Fusion Protein That Blocks CD47, Enhances the Activity of Anti-Cancer Antibodies and Checkpoint Inhibitors, and Has a Favorable Safety Profile in Preclinical Models Blood. 130: 112-112 |
| Panowski SH, Kuo T, Chen A, et al. (2016) Preclinical Evaluation of a Potent Anti-Bcma CD3 Bispecific Molecule for the Treatment of Multiple Myeloma Blood. 128: 383-383 |
| Boldajipour B, Galetto R, Sommer C, et al. (2016) Preclinical Evaluation of Allogeneic Anti-Bcma Chimeric Antigen Receptor T Cells with Safety Switch Domains and Lymphodepletion Resistance for the Treatment of Multiple Myeloma Blood. 128: 381-381 |
| Palanichamy A, Apeltsin L, Kuo TC, et al. (2014) Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. Science Translational Medicine. 6: 248ra106 |
| Benichou J, Glanville J, Prak ET, et al. (2013) The restricted DH gene reading frame usage in the expressed human antibody repertoire is selected based upon its amino acid content. Journal of Immunology (Baltimore, Md. : 1950). 190: 5567-77 |
| von Büdingen HC, Kuo TC, Sirota M, et al. (2012) B cell exchange across the blood-brain barrier in multiple sclerosis. The Journal of Clinical Investigation. 122: 4533-43 |